glp-1/gip/gcg receptor agonist Targeting central pathway of Glucose‐Dependent Insulinotropic Polypeptide, Glucagon and Glucagon‐like Peptide‐1 for metabolic regulation in obesity and type 2 diabetes - Xu - 2025 - Diabetes, Obesity and Metabolism Evaluating the indirect interaction Prime Labs Quantity:90 CT (3 Bottles)

glp-1/gip/gcg receptor agonist Targeting central pathway of Glucose‐Dependent Insulinotropic Polypeptide, Glucagon and Glucagon‐like Peptide‐1 for metabolic regulation in obesity and type 2 diabetes - Xu - 2025 - Diabetes, Obesity and Metabolism Evaluating the indirect interaction Prime Labs Quantity:90 CT (3 Bottles)

Evaluating the indirect interaction between glucagon-like peptide-1 receptor agonists and warfarin using real-world data | Journal of Thrombosis and Thrombolysis | Springer Nature Link

To learn how Celtarys can empower your next GLP‑1 drug discovery project, contact our scientific support team today

Prime Labs

Quantity:90 CT (3 Bottles)

doi:10.1186/s12871-024-02688-2 [DOI] [PMC free article] [PubMed] [Google Scholar] 48.Garcia RT, Cello JP, Nguyen MH, et al